Early pregnancy Flashcards
Discuss gestational trophoblastic disease:
-Definition
-Composition
-Incidence
-Risk factors (5)
- Spectrum of tumours of placental tissue that develop from abnormal fertilisation. Premalignant condition
- Made entirely of fetal material including syncitiotrophoblasts and cytotrophoblasts. Produces tHCG
- 1:200-1000 pregnancies
- Risk factors
-Extremes of age >15 yrs RR - 20, >45 RR = 10
-Diet deficient in protein
-Asian ethnicity
-Women with blood group A or whose partners are blood group 0 (RR 10)
-Previous GTD 1:70
How does GTD present during pregnancy (with percentages) (6)
- Vaginal bleeding (90%)
- Suspicious USS findings
- Hyperemesis (15-30%)
- Theca lutein cysts (15-30%) more likely to progress to GTN
- Hyperthyroidism (10%)
- PET (10%)
What is the presentation of GTD on USS and histo
1. Partial mole
2. Complete mole
- Partial mole
USS - focal vesicular areas, abnormal MSD, if fetus may be IUGR or multiple abnormalities
Histo- trophoblastic hyperplasia, hydropic villi +/- fetal tissue - Complete mole
USS - multiple large vesicular structures, enlarged cystic ovaries. No fetus. Snow storm
Histo-No fetal material, Marked villous hyperplasia. Hydropic swollen chorionic villi
Describe the management of molar pregnancy
Baseline: FBC, G&H, LFT, TFT, Cr, CXR
1. Suction evacuation
-Can use priming miso
-Avoid uterotonics
-Anti D if Rh-ve
-Histo to lab for confirmation on dx ( karyotype, p57 staining + in partial mole)
2. Weekly HCG until 3 consecutive normal
-Partial mole - stop once 3 x normal
-Complete mole - monthly for 6 months once 3 x normal
3. Counselling to patient and GP
-1:70 repeat
-No impact on fertility
-Contraception till cleared - COC OK. Avoid IUD until HCG normal. (increased risk perforation + dissemination)
-Early USS and HCG 6 weeks PP in following pregnancies
4. Discuss at MDM and ref to National registry
How should ongoing PVB of GTD be managed (3)
- Needs to suspect GTN or RPOC
- Consider repeat evacuation if
-Molar pregnancy was dx on histo only
-Persistently elevated HCG
-No evidence of mets on CXR
-Risk score 0-4 - Don’t do repeat evacuation if HCG >5000
- If repeat evacuation do with hysteroscopy
Describe miscarriages
-Definition
-Incidence
-Causes (5)
-Types (5)
- Pregnancy which spontaneously ends <20 weeks and <400g
- Incidence
-10-15% of clinically recognised pregnancies
-<5% after 9 weeks gestation
-10% at 30yrs. 50% by age 45 - Causes
-Chromosomal - 50%.
-Increases with age
-Less common cause as gestation increases
-Mostly Trisomies (22%) Monosomy (8%), Triploidy (8%)
-Infection - rarely
-Listeria, campylobacter, rubella, cocksackie, CMV.
-BV in second trimester
-Uterine abnormalities
-Bicornuate, septate, arcuate, DES
-Cx incompetence in 2nd trimester
-Haemoatological
-Antiphospholiid syndrome
-Thrombophillias
-Unexplained 25% - Types
-Threatened - PVB before 20/40
-Inevitable - PVB open Cx no passage of products
-Incomplete - Passage of some products
-Complete - products passed
-Septic - infected POC
Describe expectant management for miscarriage
-When to offer
-Advantages
-Disadvantages
-Success rates
-Offer if <6 weeks as first line
-Offer alternative if has condition where excessive PVB is an issue, Sx of infection, previous Obstetric related trauma
-Can wait up to 2 weeks
-FU at 14/7 if woman wants to continue expectant management
-Do PT in 3/52 to check miscarried
Advantage: non-invasive, avoid anaesthetic
Disadvantage: unpredictable, can take days to weeks, prolonged PVB and pain. Highest risk of unscheduled PVB
Success: By D7 25-50% By D14 50-80%. Most successful if incomplete 75-96%
Repeat UPT in 3 weeks if still Positive for review
Describe medical management for miscarriage
-Regimens
-Advantages
-Disadvantages
-Success rates
- Regimens
If <13 weeks
-Don’t give mife (Recent Meta analysis suggests Mife + miso better cf miso RR1.5)
-PO or PV miso is acceptable. Base on woman’s preference
-Missed miscarriage 800mcg miso can give second dose
-Incomplete miscarriage 600mcg PO
If >13 weeks
-Missed miscarriage - 200mcg PV/SL every 4-6 hrs
-Incomplete miscarriage - 200mcg PV/SL every 6 hrs - Advantages: Non invasive, avoids anaesthetic
- Disadvantage: Heavier longer PVB, May still need surgery -16%
Meta analysis suggests do difference between medical and surgical management - Success:
Overall 84%, Incomplete 93%
Mife + miso most effective form of managing miscarriage - but inconsistent data. More research needed - UPT in 3/52
Describe surgical management for miscarriage
-When to offer
-Advantages
-Disadvantages
-Success rates
-Risks (7)
- First line if haemodynamically unstable, sepsis, Heavy PVB or suspicious for GTD
- Advantages: Predictable time frame, faster resolution, shorter bleeding
Less analgesia requirement cf Miso RR 0.43 (Meta ana)
3: Disadvantages: Anaesthetic required, perforation, Ashermanns, uterine adhesions. - Success - 95-97%
- Risks:
-Overall significant risk 6%
-Bleeding - Tx 3:1000
-Infection 40:1000
-Uterine adhesions 19:1000 - mostly mild. Worse with more procedures.
-Repeat surgery 3-18:1000
-Perforation: 1:1000
-Cx trauma : <1:1000
-PTB RR 1.29
When should anti-D be prescribed post miscarriage
-When
-Dose
-Timing
When:
-Threatened miscarriage >12 weeks
-Spontaneous miscarriage >10 weeks
-Surgical management <10 weeks
-No clear evidence for spont miscarriage <10 weeks
Dose:
-Singleton up to 12 weeks - 250IU
-Multiple or >12 weeks 625 IU
Timing:
-By 72hrs
-Can have benefit up to 10 days
What is the risk of further miscarriages
After 1 miscarriage - 20% risk of repeat
After 2 miscarriages - 30% risk of repeat
After 3 or more miscarriages - 40-50% risk of repeat
Discuss the PRISM trial
-Type
-Aim
-Inclusion
-Intervention
-Primary outcome
-Results
- RCT multicentre and double blinded
- To determine if progesterone in women with threatened miscarriage improves live birth rates
- Women <12 weeks with PVB and known IUP
- 400mg BD PV progesterone vs placebo till 16/40
- Live birth >34 weeks
- Results
-Number included 4150 (~2080 each arm)
-No previous miscarriage - RR 0.99
-1-2 previous miscarriage - RR 1.05 ( CI 1.0-1.12)
-3 or more miscarriages - RR 1.28 ( CI 1.08 - 1.51)
-Any previous miscarriages RR 1.09 (CI 1.03 - 1.15)
-NNT 29 for 1 live birth
Discuss the MIST trial
-Type
-Aim
-Inclusion
-Primary outcome
-Results
- RCT
- To compare expectant, medical and surgical management of first trimester miscarriage in terms of gynaecological infection
- Women with dx missed or incomplete miscarriage <13 weeks
- Outcomes
-Primary outcome - Gynae infection at 2 weeks and 8 weeks
-Secondary outcome - Unplanned admission to hospital, unplanned surgical evacuation - Results:
-No difference with infection rates
-Significantly higher rates of unplanned admission and surgical management with expectant and medical management
Discuss the Zhang trial
-Type (2)
-Aim (1)
-Inclusion criteria (1)
-Primary outcomes (1)
-Results (4)
- Study type
-RCT to 800mcg misoprostol or Surgical ERPOC
-Randomised 3:1 - Aim
-To assess the efficacy, safety and acceptability of medical management - Inclusion criteria
-Women (n = 652) - first trimester pregnancy failure (missed miscarriage, fetal death, incomplete or inevitable miscarriage) - Primary outcome
-Treatment failure = repeat or evacuation by 30 days - Results:
-n = 650 500 to miso 160 to surgical
-84% success with medical management 71% after first dose.
-97% success with surgical management
No difference in haemorrhage, infection, ED visits between groups
-Increased blood loss in miso group (SS)
-Medical management found to be acceptable
What is the criteria for missed miscarriage (3)
Initial scan
-MSD >25mm and no visible yolk sac
-CRL >7mm and no FH seen
-No Sac or fetal growth over a time period no less than 7 days
Discuss ectopic pregnancy
-Definition
-Incidence
-Classification and incidence of each
-Risk factors
- implantation and development of pregnancy at a site other than endometrial cavity
- 1% of pregnancies
- Classification
-Tubal - 95%
-Ampullary - 55%
-Isthmic 25%
-Fimbrial 17%
-Interstitial - 2%
-Other
- CS Scar 6% of ectopic in women with >=1 previous CS
- Cervical 1%
Intramural, ovarian, abdominal - Risk factors
-Tubal damage - PID, Surgery, endometriosis
-Chromosomally abnormal pregnancies
-Progesterone containing contraception
-POP 4-6%, Jadelle - 10-20%
-IUD - Mirena 50%, CuIUD 30%
-DES, ART, Smoking, Douching
-30% no risk factors
-Previous ectopic
What are the USS signs of ectopic pregnancy
-Sensitivity, specificity
-% inconclusive on USS
-Feature - 5
- If ectopic identified Sens - 87-99%, Spec 94-99%
- 10-50% scans inconclusive
- Features:
-Empty extrauterine GS moving separately to ovary - 12-20%
-Complex inhomogenous adnexal mass moving sep from ovary 20-40% (Most common finding)
-Empty uterus
-Pseudo sac in the uterus 20%
-FF in POD
Discuss expectant management of ectopic
1. Criteria
2. Monitoring
3. Prognosis
- Criteria
-Clinically stable and pain free
-HCG <1000 (Can consider <1500)
-Tubal ectopic <35mm with no visible FHB
-Can be followed up - Monitoring
-HCG 2,4,7 then weekly until negative
-If not falling by >15% then clinical review +/- USS - Prognosis
-Up to 90% success if HCG <1000
-Up to 66% success if HCG <1500
-No difference between medical and expectant management in terms of tubal rupture, additional treatment, fertility outcomes, time to be able to conceive again
How should a PUL be managed (6)
If haemodynamically stable can:
-HCG 48hrs apart
-If rise >63% then likely IUP but some ectopics can double appropriately (HCG doesn’t tell location of pregnancy)
-Repeat USS once HCG >1500. If IUP not seen then likely ectopic
-If HCG decreases by >50% likely miscarriage. Suggest PT at 14/7 and if neg has miscarried
-Don’t use progesterone to work out if IUP or viable or ectopic
-Anything in between 50% decline and 63% rise refer to EPAU
Discuss medical management of ectopic pregnancy
-Criteria
-Meds
-Follow-up
-Prognosis
-Side effects (6)
- Criteria
-No significant pain
-Ectopic <35mm
-HCG <5000. Ideally <1500
-No Fetal heart
-No evidence of rupture
-No IUP
-Able to be followed up - Medication = methotrexate - destroys proliferating trophoblasts. Dose50mg/M2
- Follow up
-HCG 1,4,7 Continue weekly till negative
-If drop of <15% between D4-D7 = repeat treatment
- Needs USS before second dose to R/O Rupture and FHR
-Avoid pregnancy 3 month
-Avoid Alcohol and folic acid until HCG <5 - Prognosis
-90% success, 14% need repeat dose, 10% need surgery
-Better success with lower initial HCG <1000 or slow rising HCG before Rx - Side effects of methotrexate
-Bone marrow suppression
-Pulmonary fibrosis or pneumonitis
-Liver cirrhosis
-Renal failure
-GIT sx - flatulence and bloating